CARDIOMYOPATHY
Clinical trials for CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-of-its-Kind gene therapy trial for rare disease heart damage
Disease control TerminatedThis was an early-stage study to test a new gene therapy called ASP2016 for heart problems in adults with Friedreich ataxia, a rare genetic disease. The main goals were to check if the treatment was safe and how well people could tolerate it. Participants would receive a single i…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE1 • Sponsor: Astellas Gene Therapies • Aim: Disease control
Last updated Apr 01, 2026 22:56 UTC
-
Heart failure hope: could a weight loss shot ease strain on the heart?
Disease control ENROLLING_BY_INVITATIONThis study is testing if semaglutide, a medication used for weight loss, can improve heart function and symptoms in obese patients with a specific type of heart failure where the heart pumps normally but doesn't relax well. About 81 participants with obesity and this heart condit…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 01, 2026 22:56 UTC
-
Massive 10,000-Patient study aims to improve dangerous heart rhythm treatments
Knowledge-focused ENROLLING_BY_INVITATIONThis international registry study aims to collect data from 10,000 patients undergoing catheter ablation procedures for dangerous heart rhythms called ventricular tachycardia. By tracking outcomes across approximately 30 medical centers worldwide, researchers hope to better under…
Matched conditions: CARDIOMYOPATHY
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:26 UTC